Taysha Gene Therapies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.

About TSHA

Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. 

CEO
R. A. Session
CEOR. A. Session
Employees
Employees
Headquarters
Dallas, Texas
HeadquartersDallas, Texas
Founded
2019
Founded2019
Employees
Employees

TSHA Key Statistics

Market cap
127.38M
Market cap127.38M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
391.75K
Average volume391.75K
High today
$2.15
High today$2.15
Low today
$2.00
Low today$2.00
Open price
$2.14
Open price$2.14
Volume
455.76K
Volume455.76K
52 Week high
$15.34
52 Week high$15.34
52 Week low
$1.35
52 Week low$1.35

Analyst ratings

93%

of 15 ratings
Buy
93.3%
Hold
6.7%
Sell
0%

TSHA Earnings

-$1.35
-$0.90
-$0.45
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 30, Pre-Market
ActualExpected Mar 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.